- Home
- EHTH vs ANVS Comparison
EHTH vs ANVS Comparison
Compare EHTH & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHTH
- ANVS
- Stock Information
- Founded
- EHTH 1997
- ANVS 2008
- Country
- EHTH United States
- ANVS United States
- Employees
- EHTH N/A
- ANVS N/A
- Industry
- EHTH Specialty Insurers
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- EHTH Finance
- ANVS Health Care
- Exchange
- EHTH Nasdaq
- ANVS Nasdaq
- Market Cap
- EHTH 130.5M
- ANVS 110.4M
- IPO Year
- EHTH 2006
- ANVS 2020
- Fundamental
- Price
- EHTH $4.53
- ANVS $7.94
- Analyst Decision
- EHTH Hold
- ANVS Strong Buy
- Analyst Count
- EHTH 3
- ANVS 5
- Target Price
- EHTH $6.67
- ANVS $30.60
- AVG Volume (30 Days)
- EHTH 90.4K
- ANVS 158.0K
- Earning Date
- EHTH 11-06-2024
- ANVS 11-06-2024
- Dividend Yield
- EHTH N/A
- ANVS N/A
- EPS Growth
- EHTH N/A
- ANVS N/A
- EPS
- EHTH N/A
- ANVS N/A
- Revenue
- EHTH $471,200,000.00
- ANVS N/A
- Revenue This Year
- EHTH $8.91
- ANVS N/A
- Revenue Next Year
- EHTH $5.83
- ANVS N/A
- P/E Ratio
- EHTH N/A
- ANVS N/A
- Revenue Growth
- EHTH 20.76
- ANVS N/A
- 52 Week Low
- EHTH $3.58
- ANVS $4.53
- 52 Week High
- EHTH $9.45
- ANVS $22.49
- Technical
- Relative Strength Index (RSI)
- EHTH 61.67
- ANVS 44.61
- Support Level
- EHTH $4.20
- ANVS $7.84
- Resistance Level
- EHTH $4.57
- ANVS $8.48
- Average True Range (ATR)
- EHTH 0.18
- ANVS 0.41
- MACD
- EHTH 0.06
- ANVS 0.01
- Stochastic Oscillator
- EHTH 93.85
- ANVS 16.09
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare and Employer and Individual. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.